{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:54:09Z","timestamp":1769021649275,"version":"3.49.0"},"reference-count":33,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Hepatitis is one of the common liver diseases, imposing a heavy health burden worldwide. Acute hepatitis may develop into chronic hepatitis, progressing to cirrhosis and hepatocellular carcinoma. In the present study, the expression of miRNAs was quantified by real-time PCR, such as miRNA-182, 122, 21, 150, 199, and 222. Along with the control group, HCV was divided into chronic, cirrhosis, and HCC groups. The treated group was also included after the successful treatment of HCV. Biochemical parameters, such as ALT, AST, ALP, bilirubin, viral load, and AFP (HCC), were also evaluated in all of the study groups. We compared the control and diseased groups; these parameters showed significant results (p = 0.000). The viral load was high in HCV but was not detected after treatment. miRNA-182 and miRNA-21 were overexpressed with disease progression, while the expression of miRNA-122 and miRNA-199 was increased compared with the control, but decreased in the cirrhosis stage compared with chronic and HCC. The expression of miRNA-150 was increased in all of the diseased groups compared with the control, but decreased compared with the chronic group. We compared the chronic and treated groups and then all of these miRNAs were down-regulated after treatment. These microRNAs could be used as potential biomarkers for diagnosing different stages of HCV.<\/jats:p>","DOI":"10.3390\/genes14020441","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T02:32:07Z","timestamp":1675909927000},"page":"441","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum MicroRNAs as Predictors for HCV Progression and Response to Treatment in Pakistani Patients"],"prefix":"10.3390","volume":"14","author":[{"given":"Sadia","family":"Manzoor","sequence":"first","affiliation":[{"name":"Department of Biotechnology, University of Sargodha, Sargodha 40100, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran Riaz","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, University of Sargodha, Sargodha 40100, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shah","family":"Jahan","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Health Sciences, Lahore 54700, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0083-2248","authenticated-orcid":false,"given":"Muhammad Bilal","family":"Sarwar","sequence":"additional","affiliation":[{"name":"Food and Biotechnology Research Center, PCSIR Laboratories Complex Lahore, Lahore 54700, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0912-9199","authenticated-orcid":false,"given":"Asma","family":"Bashir","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Faculty of Life Sciences, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST), Karachi 75600, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-1180","authenticated-orcid":false,"given":"Sulaiman","family":"Shams","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Abdul Wali Khan University Mardan, Mardan 23200, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7646-5643","authenticated-orcid":false,"given":"Abrar","family":"Hussain","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences and Informatics, BUITEMS, Quetta 87300, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2344\/anpr-64-02-13","article-title":"Hepatitis: Sedation and anesthesia implications","volume":"64","author":"Chen","year":"2017","journal-title":"Anesth. Prog."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e2075","DOI":"10.1002\/rmv.2075","article-title":"Mitochondria in the biology, pathogenesis, and treatment of hepatitis virus infections","volume":"29","author":"Qu","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jhep.2014.06.031","article-title":"Virology and cell biology of the hepatitis C virus life cycle\u2013An update","volume":"61","author":"Dubuisson","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Warkad, S.D., Nimse, S.B., Song, K.S., and Kim, T. (2018). HCV detection, discrimination, and genotyping technologies. Sensors, 18.","DOI":"10.3390\/s18103423"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: A prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jiph.2019.11.015","article-title":"Overview of hepatitis C infection, molecular biology, and new treatment","volume":"13","author":"Rabaan","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1089\/vim.2017.0167","article-title":"Prevalence and treatment of untypable HCV variants in different districts of Punjab, Pakistan","volume":"31","author":"Zafar","year":"2018","journal-title":"Viral Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017018953","article-title":"Epidemiology of hepatitis C infection in Pakistan: Current estimate and major risk factors","volume":"27","author":"Arshad","year":"2017","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/liv.15150","article-title":"Road to elimination of HCV: Clinical challenges in HCV management","volume":"42","author":"Hayes","year":"2022","journal-title":"Liver Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/14737159.2017.1400385","article-title":"Hepatitis C point-of-care diagnostics: In search of a single visit diagnosis","volume":"17","author":"Grebely","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hayes, C.N., and Chayama, K. (2016). MicroRNAs as biomarkers for liver disease and hepatocellular carcinoma. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030280"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.clinre.2016.02.001","article-title":"Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis","volume":"40","author":"He","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/cpph.19","article-title":"Biomarkers\u2014A general review","volume":"76","author":"Aronson","year":"2017","journal-title":"Curr. Protoc. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jfma.2020.04.002","article-title":"2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations","volume":"119","author":"Yu","year":"2020","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejbas.2014.01.001","article-title":"TP53 polymorphism as a risk factor for hepatocellular carcinoma in hepatitis C virus-infected Egyptian patients","volume":"1","author":"Neamatallah","year":"2014","journal-title":"Egypt. J. Basic Appl. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","article-title":"AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection","volume":"93","author":"Sheth","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.seminoncol.2014.03.006","article-title":"Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype","volume":"41","author":"Carr","year":"2014","journal-title":"Semin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cca.2006.02.038","article-title":"Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: Experience from an Indian center","volume":"371","author":"Saini","year":"2006","journal-title":"Clin. Chim. Acta."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jceh.2014.05.013","article-title":"Epidemiology of hepatocellular carcinoma in India","volume":"4","author":"Acharya","year":"2014","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_22","first-page":"577","article-title":"Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma","volume":"6","author":"Luo","year":"2013","journal-title":"Onco Targets Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gendis.2015.01.001","article-title":"MicroRNAs: Role in hepatitis C virus pathogenesis","volume":"2","author":"Shrivastava","year":"2015","journal-title":"Genes Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/CBM-181970","article-title":"Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma","volume":"26","author":"Li","year":"2019","journal-title":"Cancer Biomark"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.virusres.2018.07.004","article-title":"Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients","volume":"255","author":"Shaheen","year":"2018","journal-title":"Virus Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e13954","DOI":"10.1111\/ijcp.13954","article-title":"Serum MicroRNAs as predictors for fibrosis progression and response to direct-acting antivirals treatment in hepatitis C virus genotype-4 Egyptian patients","volume":"75","author":"Khairy","year":"2021","journal-title":"Int. J. Clin. Pract. Suppl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajg.2019.11.003","article-title":"Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients","volume":"20","author":"Nasser","year":"2019","journal-title":"Arab. J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bihrer, V., Waidmann, O., Friedrich-Rust, M., Forestier, N., Susser, S., Haupenthal, J., and Piiper, A. (2011). Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026971"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40291-015-0148-1","article-title":"Circulating miRNA-122, miRNA-199a, and miRNA-16 as biomarkers for early detection of hepatocellular carcinoma in Egyptian patients with chronic hepatitis C virus infection","volume":"19","author":"Fawzy","year":"2015","journal-title":"Mol. Diagn Ther."},{"key":"ref_30","first-page":"e33881","article-title":"The liver MicroRNA expression profiles associated with chronic hepatitis C virus (HCV) genotype-4 infection: A preliminary study","volume":"16","author":"Helwa","year":"2016","journal-title":"Hepat. Mon."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/jmv.23987","article-title":"Micro-RNA-122 levels in acute liver failure and chronic hepatitis C","volume":"86","author":"Dubin","year":"2014","journal-title":"J. Med. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Markovic, J., Sharma, A.D., and Balakrishnan, A. (2020). MicroRNA-221: A fine tuner and potential biomarker of chronic liver injury. Cells, 9.","DOI":"10.3390\/cells9081767"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1479-5876-10-151","article-title":"Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection","volume":"10","author":"Bala","year":"2012","journal-title":"J. Transl. Med."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/2\/441\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:27:57Z","timestamp":1760120877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/2\/441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["genes14020441"],"URL":"https:\/\/doi.org\/10.3390\/genes14020441","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]}}}